1Carrnthers A,Kinene K,Carruthers J,et al.Botulinum exotoxin A use in clinical dermatology[J]. Am Acad Dematol,1996,34(5):788-797.
2Bhakta BB, Cozens JA, Bamford JM, et al.Use of botulinum toxin in stroke patients with severe upper limb spasticity[J]. J Neurol Neurosurg Psychiatry, 1996, 61: 30-35.
3Hilde MF,Willy JD,Beat ES,et al.Effect of a therapeutic intervention for the hemiplegic upper limb in the acute phase after stroke: a single-blind randomized controlled muhicenter trial[J].Stroke,1998,29:785-792.
5El-Etribi MA, Salem ME, El-Shakankiry HM, et al. The effect of botulinum toxin type-A injection on spasticity,range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study[J]. International J Rehab Res,2004,27 (4):275-281.
6Schurch B,Hauri D,Rodic B,et al.Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia:a prospective study in 24 spinal cord injury patients[J].J Urol,1996,155:1023-1027.
8Hyman N, Barnes M, Bhakta B, et al.Botulinum toxin (Dysport) treatment of hip adductor, spasticity in multiplesclerosis: A prospective, randomized,double blind, placebo controlled, doseranging study[J]. J Neurol Neurosurg Psychiatry,2000,68:707-712.
9Hsiung GY,Das SK,Ranawaya R,et al.Long-term eficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period[J].Mov Disord,2002,17(6):1288-1293.
1Anthony BW.Assessment of muscle tone.Age Ageing,2000,29:385-386.
2Brin MF. Dosing, Administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve, 1997, 6:208.
3Das TK,Park DM. Effect of treatment with botulinum toxin on spasticity.Postgrad Med J, 1989,65:208-210.
4Hilde MF,Willy JD,Beat ES, et al. Effect of a therapeutic intervention for the hemiplegic upper limb in the acute phase after stroke a singleblind, randomized, controlled multicenter trial. Stroke, 1998,29: 785-792.
5Bakheit AMO, Thilmann AF, Ward AB, et al. A randomized doubleblind placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (dysport) with placebo in upper limb spasticity after stroke. Stroke, 200
6Lagalla G, Danni M, Reiter F, et al. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. AM J Phys Med Rehabil,2000,79:377-384.
7Schurch B, Stoehrer M, Kramer G, et al. Botulinum -A toxin for treating detrusor hyperreflexia in spinal cord injured patients:a new alternative to anticholinergic drugs? Preliminary results. J Urol, 2000,164:692-697.
8Abrams P,Larsson G, Chapple C, et al. Factors involved in the success of antimuscarintc treatment. BJU Int, 1999,83 (suppl) :42-47.
9Brindley GS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia, 1994,32: 795-805.
10de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn, 1998,17: 513-523.
